Zobrazeno 1 - 3
of 3
pro vyhledávání: '"mFOLFIRINOX chemotherapy gemcitabine cholangiocarcinoma"'
Autor:
Lu Zou, Xuechuan Li, Xiangsong Wu, Jiujie Cui, Xuya Cui, Xiaoling Song, Tai Ren, Xusheng Han, Yidi Zhu, Huaifeng Li, Wenguang Wu, Xu’an Wang, Wei Gong, Liwei Wang, Maolan Li, Wan Yee Lau, Yingbin Liu
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Gemcitabine plus platinum as the first-line chemotherapy for cholangiocarcinoma (CCA) has limited efficacy. The aim of this study was to evaluate the effectiveness of modified FOLFIRINOX (mFOLFIRINOX) compared to that of gemcitabi
Externí odkaz:
https://doaj.org/article/9f5fedbdd8a34889a12f69b7bbae770d
Autor:
Liwei Wang, Lu Zou, Xuya Cui, Xiangsong Wu, Xiaoling Song, Yidi Zhu, Xuechuan Li, Wan Yee Lau, Maolan Li, Wei Gong, Tai Ren, Jiujie Cui, Huaifeng Li, Yingbin Liu, Wenguang Wu, Xu-Sheng Han, Xu-An Wang
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Background Gemcitabine plus platinum as the first-line chemotherapy for cholangiocarcinoma (CCA) has limited efficacy. The aim of this study was to evaluate the effectiveness of modified FOLFIRINOX (mFOLFIRINOX) compared to that of gemcitabine plus o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a0b6bb2d2cf8c59bad13dd8e7dc4f5
https://pubmed.ncbi.nlm.nih.gov/34266407
https://pubmed.ncbi.nlm.nih.gov/34266407
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.